TD Asset Management’s ADC Therapeutics ADCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-74,690
| Closed | -$161K | – | 1411 |
|
|
2023
Q2 | $161K | Hold |
74,690
| – | – | ﹤0.01% | 1378 |
|
|
2023
Q1 | $146K | Hold |
74,690
| – | – | ﹤0.01% | 1393 |
|
|
2022
Q4 | $287K | Hold |
74,690
| – | – | ﹤0.01% | 1363 |
|
|
2022
Q3 | $365K | Sell |
74,690
-17,600
| -19% | -$86K | ﹤0.01% | 1344 |
|
|
2022
Q2 | $734K | Hold |
92,290
| – | – | ﹤0.01% | 1235 |
|
|
2022
Q1 | $1.36M | Hold |
92,290
| – | – | ﹤0.01% | 1181 |
|
|
2021
Q4 | $1.86M | Hold |
92,290
| – | – | ﹤0.01% | 1147 |
|
|
2021
Q3 | $2.51M | Buy |
92,290
+8,000
| +9% | +$217K | ﹤0.01% | 1018 |
|
|
2021
Q2 | $1.77M | Hold |
84,290
| – | – | ﹤0.01% | 1131 |
|
|
2021
Q1 | $2.06M | Buy |
84,290
+31,801
| +61% | +$776K | ﹤0.01% | 1095 |
|
|
2020
Q4 | $1.68M | Buy |
+52,489
| New | +$1.68M | ﹤0.01% | 1072 |
|